Our mission is to improve the quality of human cell culture and research everywhere and become the go-to manufacturer of iPSC-derived cells for all applications. With Life Sciences and Pharmaceutical research still relying on research methods from the 20th century, the stage is set for next-generation human cell models.

Celogics’ aim is to make quality human cells that are not just great iPSC-derived cells but the best functional cells for the research subject. We will listen to our users’ needs and provide the high-quality cells they deserve. Our initial product offering will be research-use-only iPSC-derived cell products, under our Celo.Cells brand. These cell products are used in drug discovery, drug safety screening, and disease modeling. 

We are a newly formed joint venture between Curi Bio (www.curibio.com) & NEXEL (www.nexel.co.kr) and building out a 22,000 square feet facility – reach out and join our exciting project!

Celogics

Org chart

Teams

Offices